RE:Reading the tea leaves...
My take on the newsletter.
Timing is not the issue with this newsletter. This could be the most important newsletter released by Theralase ever, since it will confirm what we shareholders and many watching have been waiting for......25 completed trial results and with a high CR percentage. This one needs accuracy, tranparency and understanding enough to excite the market into buying shares. By the time the next newsletter is due 3 months from now, hopefully many warrants will be cashed in for shares and there will be more money in the coffers and it may be coinciding with a private placement at which time a higher share price will result in lower dilution. This soon to arrive newsletter is also about increasing believed investment intellegence and giving the market as a whole the belief that buying TLT shares is a smart investment. Yes we need institutional buying and that is what the next newsletter is likely being aimed at. IMO I'm certain with her experience Vera understands the quality newsletter concept. .